Rights and permissions
About this article
Cite this article
Alemtuzumab: an effective front-line option for CLL?. Inpharma Wkly. 1548, 15–16 (2006). https://doi.org/10.2165/00128413-200615480-00040
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615480-00040